Currently out of the existing stock ratings of David Adlington, 32 are a HOLD (48.48%), 19 are a BUY (28.79%), 15 are a SELL (22.73%).

David Adlington

Work Performance Price Targets & Ratings Chart

Analyst David Adlington works at JPMORGAN with a stock forecast success ratio of 38.36% fulfilled within 177.71 days on average.

David Adlington’s has documented 131 price targets and ratings displayed on 8 stocks. The coverage is on Healthcare, Communication Services sectors.

Most recent stock forecast was given on FMS, Fresenius Medical Care at 03-Nov-2023.

Wall Street Analyst David Adlington

Analyst best performing recommendations are on AMFPF (AMPLIFON S.P.A).
The best stock recommendation documented was for PHG (KONINKLIJKE PHILIPS NV ADR) at 10/19/2021. The price target of $42.31 was fulfilled within 1 day with a profit of $1.07 (2.59%) receiving and performance score of 25.95.

Average potential price target upside

FMS Fresenius Medical Care PHG Koninklijke Philips NV ADR SE Sea Ltd SNN Smith & Nephew SNATS FSNUY Fresenius SE KGaA ADR SMMNY Siemens Healthineers AG ADR ALC Alcon AG AMFPF Amplifon S.p.A

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

34

4 months 5 days ago

0/2 (0%)

$15.46 (83.39%)

36.47

$17.11 (88.38%)

50.57

4 months 20 days ago

4/15 (26.67%)

$19.39 (113.52%)

137

Sell

29.84

$10.48 (54.13%)

33.99

4 months 26 days ago

3/15 (20%)

$12.41 (71.20%)

116

40.12

$20.76 (107.23%)

44.25

5 months 9 days ago

0/5 (0%)

$22.47 (127.31%)

Hold

24

$4.64 (23.97%)

28

5 months 18 days ago

4/9 (44.44%)

$6.73 (38.97%)

153

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is David Adlington is most bullish on?

Potential upside of $10.48 has been obtained for FMS (FRESENIUS MEDICAL CARE)

Which stock is David Adlington is most reserved on?

Potential downside of -$11.05 has been obtained for SNN (SMITH & NEPHEW SNATS)

What Year was the first public recommendation made by David Adlington?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?